drugset / Trial / NCT03425474
Study of Remimazolam Tosilate in Patients Undergoing Diagnostic Upper GI Endoscopy
RandomizedParallel-groupSingle-blindOther
Summary
The purpose of this study is to evaluate the safety and efficacy of the sedation for Remimazolam or Propofol in patients undergoing diagnostic upper GI endoscopy.
Timeline
- Start
- 2017-09-01
- Primary completion
- 2017-11-10
- Completion
- 2017-11-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Propofol | Small molecule | 1.5 mg/kg | — |
| Subject | Remimazolam | Small molecule | 5 mg | — |
Indications
No indication recorded.